CLINICAL_TRIALS
trial_result
· 2017-01-13
Clinical Trial Update: A Trial of Levodopa in Angelman Syndrome [Phase 2, Phase 3]
Summary
A Phase 2/3 clinical trial evaluating levodopa in Angelman Syndrome has completed with results posted in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Wen-Hann Tan | Conditions: Angelman Syndrome | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2017-01-13